These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31292241)

  • 1. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
    Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
    Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
    J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.
    Garrison AR; Smith DR; Golden JW
    Viruses; 2019 Jun; 11(7):. PubMed ID: 31261754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
    Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjärvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
    Elife; 2022 Apr; 11():. PubMed ID: 35437144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.
    Bente DA; Alimonti JB; Shieh WJ; Camus G; Ströher U; Zaki S; Jones SM
    J Virol; 2010 Nov; 84(21):11089-100. PubMed ID: 20739514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
    Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
    Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis.
    Nasirian H
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101429. PubMed ID: 32062190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
    Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crimean-Congo hemorrhagic fever.
    Whitehouse CA
    Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus.
    Spengler JR; Estrada-Peña A; Garrison AR; Schmaljohn C; Spiropoulou CF; Bergeron É; Bente DA
    Antiviral Res; 2016 Nov; 135():31-47. PubMed ID: 27713073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single mutation in Crimean-Congo hemorrhagic fever virus discovered in ticks impairs infectivity in human cells.
    Hua BL; Scholte FE; Ohlendorf V; Kopp A; Marklewitz M; Drosten C; Nichol ST; Spiropoulou C; Junglen S; Bergeron É
    Elife; 2020 Oct; 9():. PubMed ID: 33084573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.